1. Search Result
Search Result
Results for "

magnetic resonance

" in MedChemExpress (MCE) Product Catalog:

19

Inhibitors & Agonists

1

Fluorescent Dye

1

Peptides

1

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B1724

    Perfluorooctyl bromide; 1-Bromoperfluorooctane; PFOB

    Others Metabolic Disease Cancer
    Perflubron (Perfluorooctyl bromide) is a contrast medium for magnetic resonance imaging and sonography. Perflubron can be emulsified with egg phospholipids (EYP) and shows exceptionally fast excretion characteristics .
    Perflubron
  • HY-B0933
    Gadoteridol
    1 Publications Verification

    SQ-32692; Gd-HP-DO3A

    Biochemical Assay Reagents Neurological Disease
    Gadoteridol is a gadolinium-based magnetic resonance imaging (MRI) contrast agent, used in the imaging of the central nervous system .
    Gadoteridol
  • HY-W034551

    Others Others
    DOTA-tri(t-butyl ester) can be used in the synthesis of generations 3 (G3) nanoglobular magnetic resonance imaging (MRI) contrast agents for MR angiography and tumor angiogenesis imaging .
    DOTA-tri(t-butyl ester)
  • HY-B1724R

    Others Metabolic Disease Cancer
    Perflubron (Standard) is the analytical standard of Perflubron. This product is intended for research and analytical applications. Perflubron (Perfluorooctyl bromide) is a contrast medium for magnetic resonance imaging and sonography. Perflubron can be emulsified with egg phospholipids (EYP) and shows exceptionally fast excretion characteristics .
    Perflubron (Standard)
  • HY-B0933A

    SQ-32692 pentahydrate; Gd-HP-DO3A pentahydrate

    Biochemical Assay Reagents Neurological Disease
    Gadoteridol pentahydrate is a gadolinium-based magnetic resonance imaging (MRI) contrast agent, used in the imaging of the central nervous system .
    Gadoteridol pentahydrate
  • HY-150979

    Fluorescent Dye Cancer
    Gd-NMC-3 is a near-infrared fluorescence/magnetic resonance (NIRF/MR) bimodal imaging probe. Gd-NMC-3 shows high resolution and sensitivity in tumor imaging with good biocompatibility, indicating huge application potential .
    Gd-NMC-3
  • HY-A0266

    Biochemical Assay Reagents Others
    Gadobenic acid, a complex of gadolinium with the ligand BOPTA, is an magnetic resonance imaging (MRI) contrast agent .
    Gadobenic acid
  • HY-16217A

    ZK 135079 hydrate

    Biochemical Assay Reagents Others
    Gadobutrol (ZK 135079) hydrate is a nonionic paramagnetic macrocyclic gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) .
    Gadobutrol hydrate
  • HY-136476A

    Biochemical Assay Reagents Others
    Mn(II) protoporphyrin IX is a potential intravenous paramagnetic magnetic resonance contrast agent. Mn(II) protoporphyrin IX maintains strong paramagnetic properties .
    Mn(II) protoporphyrin IX
  • HY-16217
    Gadobutrol
    1 Publications Verification

    ZK 135079

    Biochemical Assay Reagents Cancer
    Gadobutrol (Gd-DO3A-butrol; ZK 135079) is a nonionic paramagnetic macrocyclic gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) .
    Gadobutrol
  • HY-A0167
    Gadopentetate dimeglumine
    2 Publications Verification

    SH-L-451A; Gadopentetic acid dimeglumine salt

    Others Cancer
    Gadopentetate dimeglumine (SH-L-451A) is used in combination with magnetic resonance imaging (MRI) to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on the MRI.
    Gadopentetate dimeglumine
  • HY-148465

    Biochemical Assay Reagents Cardiovascular Disease Cancer
    Gadoteric acid is a macrocyclic, paramagnetic, gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) of the brain, spine, and related tissues. In particular, Gadoteric acid is able to detect and visualize areas of blood-brain barrier disruption and abnormal vascular distribution .
    Gadoteric acid
  • HY-16219

    Gd-EOB-DTPA Disodium; ZK 139834

    Biochemical Assay Reagents Cancer
    Gadoxetate Disodium (Gd-EOB-DTPA Disodium) is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system, which accumulates in normal, functioning hepatocytes. Gadoxetate Disodium (Gd-EOB-DTPA Disodium) is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging .
    Gadoxetate Disodium
  • HY-100468

    Others Cancer
    REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM, which directly binds to REV7 in nuclear magnetic resonance analyses, and inhibits the reactivation of a reporter plasmid containing an interstrand crosslink (ICL) in between the promoter and reporter regions .
    REV7/REV3L-IN-1
  • HY-124304

    LOE-908

    TRP Channel SARS-CoV Neurological Disease
    Pinokalant is a broad-spectrum and non-selectivecation channel inhibitor. Pinokalant significantly reduces cortical infarct volume. Pinokalant o improves the metabolic and electrophysiologic status of the ischemic penumbra. Pinokalant reduces lesion size on magnetic resonance images in the acute phase following middle cerebral artery occlusion in rats. Pinokalant has the potential for the research of stroke. Pinokalant also shows anti-SARS-CoV-2 activity .
    Pinokalant
  • HY-106594A

    Iron(III) ferrocyanide; Milori blue

    Bacterial Infection Others Cancer
    Prussian blue insoluble (Iron(III) ferrocyanide) is a good adsorbent to be used as antidotes for poisoning with cesium or thallium ions. Prussian blue insoluble (Iron(III) ferrocyanide) has anticancerous and antibacterial properties. Prussian blue insoluble (Iron(III) ferrocyanide) can be used as a contrast agent in photoacoustic and magnetic resonance imaging (MRI). Prussian blue insoluble can be used for contrast agents, antidotes and cancer research .
    Prussian blue insoluble
  • HY-108760

    Gd-DOTA; Magnescope; P-449

    Biochemical Assay Reagents Cardiovascular Disease Others Neurological Disease
    Gadoterate meglumine (Gd-DOTA; P-449) is a non-specific paramagnetic gadolinium complex used as a contrast enhancer in magnetic resonance imaging (MRI). Gadoterate meglumine paramagnetics in MRI can change the uniformity of the local magnetic field, resulting in a shorter relaxation time for neighboring protons. Gadoterate meglumine's gadoterate ions combine with the ligand DOTA (1,4,7, 10-Tetraazacyclododecane-N,N',N ",N "-tetraacetic acid) to form a stable complex. This stability helps prevent gadolinium ions from dissociating from the complex, thereby reducing potential toxicity. Gadoterate meglumine, as a contrast agent in MRI, is able to shorten the longitudinal relaxation time (T1) of tissue, resulting in a brighter signal in MRI images. Gadoterate meglumine can be used for the study of the central nervous system (such as the brain and spinal cord), abdominal, pelvic organs, breast, bone and joint imaging, angiography, and cardiac electrophysiology .
    Gadoterate meglumine
  • HY-P4805

    Neuropeptide Y Receptor Metabolic Disease
    Peptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist .
    Peptide YY (13-36) (canine, mouse, porcine, rat)
  • HY-N0926A
    Columbamine chloride
    1 Publications Verification

    Columbamin chloride; Dehydroisocorypalmine chloride

    Others Others
    Columbamine (Columbamin; Dehydroisocorypalmine) chloride is an alkaloid .
    Columbamine chloride

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: